Multiple superficial injuries of ankle and foot

ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S90.7 Cause of death: ICD-10 — S90.7 2 out of 7 registries used, show all original rules.	45
4. Check minimum number of events None	45
5. Include endpoints None	45
6. Filter based on genotype QC (FinnGen only)	45

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ANKLE_FOOT

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S90
Name in latin: Laesiones superficiales multae tarsi/pedis

NAME	ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT
CONTROL_EXCLUDE	ST19_INJURI_ANKLE_FOOT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S907
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S907
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Multiple superficial injuries of ankle and foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	45	29	16
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	44.34	46.28	40.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2.59

2.32

3.3

2.7

82.8

28.8

ng/l

0.32

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.69

2.08

1.2

1.3

35.9

31.0

iu/ml

—

(1761868) Lipid panel - Serum or Plasma

163

0.38

1.88

1.8

2.1

—

(42870588) Differential panel, method unspecified - Blood

110

2.26

1.80

7.3

6.1

—

(3022313) Gas panel - Capillary blood

4.18

1.76

5.4

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4.18

1.76

1.8

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

147

2.15

1.69

3.8

3.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

157

2.13

1.65

2.8

2.7

118.7

75.7

ug/l

0.67

152

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.30

1.64

1.0

1.3

—

(40758558) Short blood count panel - Blood

2.18

1.60

4.6

5.8

—

(3026008) Bacteria identified in Urine by Culture

2.12

1.36

1.6

2.8

—

(3033658) Prothrombin time (PT) actual/Normal

2.13

1.32

3.1

3.9

92.9

101.0

0.48

(4010399)

2.83

1.25

1.2

—

(3019225) pH of Specimen

2.50

1.23

10.2

3.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

1.20

0.0

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2.55

1.12

2.2

2.6

0.2

g/l

—

(3044640) Blood type and Crossmatch panel - Blood

1.97

1.10

2.2

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.10

1.06

2.3

2.4

—

(3013115) Eosinophils [#/volume] in Blood

179

1.73

0.96

7.6

6.6

0.2

e9/l

0.23

167

(3022217) INR in Platelet poor plasma by Coagulation assay

2.31

0.95

2.3

15.8

—

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.99

0.92

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.47

0.91

2.2

4.5

—

(3003694) ABO and Rh group [Type] in Blood

108

1.75

0.90

1.9

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.08

0.88

2.0

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2.08

0.88

5.0

2.0

25.0

25.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

100

1.75

0.87

2.0

1.9

100.3

93.0

pmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.01

0.85

1.8

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.89

0.84

1.2

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

0.00

0.80

0.0

2.6

—

16329.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

215

1.64

0.80

4.5

3.6

—

44.1

—

(3042936) Bacteria identified in Isolate by Culture

1.79

0.72

2.7

1.8

—

(3032080) INR in Blood by Coagulation assay

1.60

0.64

4.6

5.2

1.0

1.1

inr

—

(3000494) Fungus identified in Specimen by Culture

1.88

0.61

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

142

0.62

0.58

2.5

2.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

171

0.66

0.53

5.1

6.8

10.0

10.8

umol/l

0.09

165

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

311

1.56

0.52

3.9

3.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

367

1.81

0.51

17.1

10.3

17.2

19.0

mg/l

0.23

274

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

0.60

0.48

1.8

1.5

1.9

1.3

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

359

1.65

0.48

17.7

9.6

139.6

139.8

mmol/l

0.21

348

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

271

1.46

0.48

5.2

4.1

14.2

14.7

pmol/l

0.61

253

(36304419) Bacteria [Presence] in Urine

1.50

0.46

2.9

2.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.69

0.45

2.0

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.40

0.43

2.9

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

2.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.41

0.0

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.62

0.40

1.0

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.44

0.39

7.0

3.6

29.4

30.8

—

(3013512) EKG study

1.48

0.38

3.8

2.5

—

(3018095) Leukocytes [#/volume] in Urine

119

1.39

0.38

3.6

2.9

8.6

66.3

e6/l

—

(3015736) pH of Urine

131

0.70

0.37

2.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

362

1.58

0.37

18.0

9.6

4.0

3.9

mmol/l

0.32

351

(3013707) Erythrocyte sedimentation rate by Westergren method

248

1.34

0.35

4.6

4.0

11.3

8.5

mm/h

0.76

235

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.40

0.34

2.9

2.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

112

1.36

0.33

2.0

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

335

1.37

0.32

6.2

4.6

1.6

1.7

mu/l

0.20

317

(40768804) Tissue Pathology biopsy report

142

1.32

0.31

1.8

1.7

—

(3023368) Bacteria identified in Blood by Culture

1.28

0.29

4.8

4.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.28

0.29

3.1

3.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.33

0.28

1.8

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

234

1.26

0.25

4.2

3.5

—

(36660697) Celiac disease serology panel - Serum

1.39

0.24

1.2

1.1

—

(3000492) Spirometry study

1.25

0.23

1.2

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.25

0.23

1.8

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.20

0.0

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.20

0.0

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.20

0.0

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

355

1.24

0.15

13.2

10.7

40.7

41.2

0.34

305

(3041096) Erythrocytes [Presence] in Urine by Automated

115

0.83

0.12

2.0

2.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

107

1.17

0.10

2.9

2.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

390

1.23

0.09

15.6

11.2

81.2

71.6

umol/l

0.33

390

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1.12

0.08

1.5

1.9

2.5

2.6

mg/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.06

0.07

2.7

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

111

0.87

0.07

1.7

2.2

48.3

53.1

u/l

—

103

(3021601) Nitrite [Presence] in Urine by Test strip

169

1.11

0.06

3.6

4.3

0.0

estimate

—

(3044889) 12 lead EKG panel

231

0.91

0.06

3.3

2.8

—

(3009261) Glucose [Presence] in Urine by Test strip

173

0.97

0.00

2.4

3.2

0.0

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

114

0.95

0.00

3.4

2.0

—

(3035350) Ketones [Presence] in Urine by Test strip

172

0.98

0.00

2.4

3.0

0.0

estimate

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

0.00

0.0

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

24.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

0.00

0.0

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.3

—

107.3

—

(3018572) Chloride [Moles/volume] in Blood

0.00

0.0

7.1

—

106.9

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.8

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

0.0

2.9

—

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

2.3

—

5.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

49.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

2.3

—

62.7

—

(4094501)

0.00

0.0

1.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3011412) CD3 cells [#/volume] in Blood

0.00

0.0

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

2.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.3

—

117.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

215.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.0

1.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

9.2

—

(4211845)

0.00

0.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.0

—

35.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.93

0.00

3.0

2.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(4306422)

0.00

0.0

1.3

—

(3039000) Anion gap in Blood

0.00

0.0

7.1

—

10.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

6.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

360

1.00

0.00

4.0

3.4

1.4

1.5

mmol/l

0.90

341

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.00

0.0

5.0

—

25.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT – Multiple superficial injuries of ankle and foot

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Multiple superficial injuries of ankle and foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Multiple superficial injuries of ankle and foot (ST19_MULTIPLE_SUPERF_INJURI_ANKLE_FOOT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints